Lyell Immunopharma, Inc. (LYEL) Net Margin
- 2026-06-30: Net Margin -1118875.00%.
- 2026-03-31: Net Margin -1207650.00%.
- 2025-12-31: Net Margin -2345383.33%.
- 2025-09-30: Net Margin -258973.33%.
Complete source-backed net margin history.
- Available history
- 2019-12-31 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|
| 2026-06-30 | -1118875.00% |
|---|
| 2026-03-31 | -1207650.00% |
|---|
| 2025-12-31 | -2345383.33% |
|---|
| 2025-09-30 | -258973.33% |
|---|
| 2025-06-30 | -533550.00% |
|---|
| 2025-03-31 | -745642.86% |
|---|
| 2024-12-31 | -1744863.64% |
|---|
| 2024-09-30 | -131126.47% |
|---|
| 2024-06-30 | -352376.92% |
|---|
| 2024-03-31 | -2022233.33% |
|---|
| 2023-12-31 | -407153.85% |
|---|
| 2023-09-30 | -203412.00% |
|---|
| 2023-06-30 | -236629.63% |
|---|
| 2023-03-31 | -103013.85% |
|---|
| 2022-12-31 | -17.35% |
|---|
| 2022-09-30 | -2341800.00% |
|---|
| 2022-06-30 | -101.63% |
|---|
| 2022-03-31 | -12322.60% |
|---|
| 2021-12-31 | -2966.19% |
|---|
| 2021-09-30 | -1774.05% |
|---|
| 2021-06-30 | -2381.85% |
|---|
| 2021-03-31 | -2251.25% |
|---|
| 2020-12-31 | -1680.67% |
|---|
| 2020-09-30 | -3338.22% |
|---|
| 2020-06-30 | -3228.22% |
|---|
Annual Net Margin
| Date | Net Margin |
|---|
| 2025-12-31 | -762355.56% |
|---|
| 2024-12-31 | -562285.25% |
|---|
| 2023-12-31 | -180486.15% |
|---|
| 2022-12-31 | -216.24% |
|---|
| 2021-12-31 | -2349.47% |
|---|
| 2020-12-31 | -2636.31% |
|---|
| 2019-12-31 | -19692.09% |
|---|